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     The present study was undertaken to conduct cell science studies regarding role of 
cyclooxygenase (COX)-1, the constitutive COX isoform, in adipogenesis and biosynthesis of 
prostacyclin called also prostaglandin (PG) I2 at the maturation phase of adipocytes using cultured 
preadipogenic cells with the ability to differentiate into adipocytes. PGs are synthesized through the 
arachidonate COX pathway in which the enzymatic reaction of PGH synthase alternatively called 
COX is the rate-limiting step for the generation of PGs after the release of free arachidonic acid. The 
COX enzyme is known to occur as two types of isoforms, including the constitutive COX-1 and the 
inducible COX-2. Cultured mouse preadipogenic 3T3-L1 cells have been useful for the studies on the 
regulation of the arachidonate COX pathway and the role of the products in the control of 
adipogenesis and other functions of adipocytes because of the established culture conditions consisted 
of the growth, differentiation, and maturation phases. Therefore, I have been studying the gene 
expression of the biosynthetic enzymes of the COX pathway and the roles for endogenous and 
exogenous PGs at different life stages. The delayed synthesis of PGE2 and PGF2α by cultured 
preadipocytes can be simulated by the addition of a mixture of active phorbol diester and calcium 
ionophore, which was accompanied by the induction of COX-2. Alternatively, our study has shown 
that cultured adipocytes during the maturation phase enhance the ability to generate endogenous PGJ2 
derivatives and contribute to the up-regulation of adipogenesis. Since both specific inhibitors for 
COX-1 and COX-2 were found to be effective in the inhibition of the generation of endogenous PGJ2 
derivatives, both COX isoforms could be responsible for the production of them. Some of other 
studies have reported the selective inhibitors for COX-1 and COX-2 similarly accelerated the 
differentiation of 3T3-L1 adipocytes in the modified differentiation medium without dexamethasone 
in the presence of a peroxisome proliferator-activated receptor γ (PPARγ) agonist or in another culture 
medium supplemented with free arachidonic acid. Thus, COX inhibitors sometimes exert different 
effects on adipogenesis by the use of modified differentiation medium with varied hormone cocktails. 
As well, it should be noted that some of COX inhibitors by themselves act as active ligands for PPARγ 
at higher concentrations. On the basis of the findings and uncertainties as described above, I attempted 
to investigate the contribution of the constitutive COX-1 to adipogenesis during the maturation phase 
of adipocytes. For this analysis, I undertook the approach to selectively suppress the expression of 
COX-1 by making use of cultured preadipocytes transfected stably with COX-1 oriented in the 
antisense direction.   
     The arachidonate COX pathway is involved in the generation of several types of endogenous 
PGs with opposite effects on adipogenesis at different life stages of adipocytes. However, specific role 
of COX isoforms, the rate limiting enzymes for the pathway, remains elusive in the regulation of the 
endogenous synthesis of PGs. This study was aimed at the selective suppression of the constitutive 
COX-1 in cultured preadipocytes by the isolation of cloned preadipocytes transfected stably with a 
mammalian expression vector harboring cDNA encoding mouse COX-1 in the antisense direction. The 
gene expression analysis revealed that the transcript and protein levels of the constitutive COX-1 were 
substantially suppressed in the isolated cloned transfectants with antisense COX-1. By contrast, the 
expression of the inducible COX-2 was not affected in the stable transfectants with antisense COX-1. 
All the cloned stable transfectants with antisense COX-1 exhibited the significant reduction in the 
immediate synthesis of PGE2 serving as an anti-adipogenic factor. The sustained expression of COX-1 
at the antisense direction induced the appreciable stimulation of fat storage in adipocytes during the 
maturation phase, which was associated with the higher expression levels of adipocyte-specific genes, 
indicating the positive regulation of adipogenesis program. Moreover, the up-regulation of 
adipogenesis is accompanied by higher production of J2 series PGs including 15-deoxy-Δ12,14-PGJ2 
and Δ12-PGJ2 known as pro-adipogenic factors by the transfectants with antisense COX-1. The results 
suggest that the inducible COX-2 can contribute to the endogenous synthesis of PGJ2 derivatives 
acting as autocrine mediators to simulate adipogenesis during the maturation phase by way of 
compensation for the suppressed expression of the constitutive COX-1. 
     Earlier studies have reported that carbaprostacyclin, a stable analogue of prostacyclin also called 
PGI2, stimulates terminal differentiation of Ob1771 mouse pre-adipose cells in serum-free 
hormone-supplemented medium. Furthermore, under the same conditions, they recognized the 
pro-adipogenic effect of arachidonic acid, which was blocked by COX inhibitors. According to the 
ability of those cells to 6-keto-PGF1α, a stable hydrolysis product of unstable parent PGI2, and PGF2α, 
those prostanoids are considered as autocrine mediators in the process of adipose conversion. 
Nevertheless, the pro-adipogenic action of endogenous PGI2 remains obscure due to the instability of 
PGI2 and its uncertainty of effective concentration of the parent form. Biologically active PGI2 is 
rapidly hydrolyzed to inactive 6-keto-PGF1α in most biological fluids. It should be noted that different 
cell types and alterations in the culture conditions of cultured adipocytes and precursor cells would 
gave contradictory results on adipogenesis. For example, PGF2α serves as anti-adipogenic factor in 
cultured 3T3-L1 cells in contrast to the stimulatory effect on the adipocyte differentiation of cultured 
Ob1771 pre-adipose cells as described above. In addition, a previous study observed that the repeated 
addition of exogenous PGI2 to cultured 3T3-L1 cells inhibited insulin- and indomethacin-mediated 
adipocyte differentiation. Earlier, cultured 3T3-L1 cells have been described to generate PGI2 as an 
immediate response to calcium ionophore A23187 for 5 min or by the incubation with extracellular 
arachidonic acid. However, until now the biosynthesis of PGI2, which is usually quantified as the 
levels of stable 6-keto-PGF1α, has not been monitored comprehensively at different life stages of 
adipocytes through the growth, differentiation, and maturation phases. In this study, I obtained an 
antiserum specific for 6-keto-PGF1α and used for the development of a sensitive, convenient 
solid-phase enzyme-linked immunosorbent assay (ELISA) for the quantification of 6-keto-PGF1α. 
After the confirmation of the precision and accuracy of our ELISA, this immunological assay was 
applied to the determination of 6-keto-PGF1α reflecting the endogenous levels of PGI2 synthesized by 
cultured 3T3-L1 cells at different life stages of adipogenesis.  
     Prostacyclin alternatively called PGI2 is an unstable metabolite synthesized by the arachidonate 
COX pathway. Earlier studies have suggested that prostacyclin analogues can act as a potent effector 
of adipose differentiation. However, biosynthesis of PGI2 has not been determined comprehensively at 
different life stages of adipocytes. PGI2 is rapidly hydrolyzed to the stable product, 6-keto-PGF1α, in 
biological fluids. Therefore, the generation of PGI2 can be quantified as the amount of 6-keto-PGF1α. 
In this study, I attempted to develop a solid-phase ELISA using a mouse antiserum specific for 
6-keto-PGF1α. According to the typical calibration curve of our ELISA, 6-keto-PGF1α can be 
quantified from 0.8 pg to 7.7 ng in an assay. The evaluation of our ELISA revealed the higher 
specificity of our antiserum without the cross-reaction with other related prostanoids while it exhibited 
only the cross-reaction of 1.5% with PGF2α. The resulting ELISA was applied to the quantification of 
6-keto-PGF1α generated endogenously by cultured 3T3-L1 cells at different stages. The cultured cells 
showed the highest capability to generate 6-keto-PGF1α during the maturation phase of 4-6 days, 
which was consistent with the coordinated changes in the gene expression of PGI synthase and the IP 
receptor for PGI2. Following these events, the accumulation of fats was continuously promoted up to 
14 days. Thus, the present immunological assay specific for 6-keto-PGF1α is useful for monitoring the 
endogenous levels of the unstable parent PGI2 at different life stages of adipogenesis and for further 
studies on the potential association with the up-regulation of adipogenesis in cultured adipocytes. 
 
 
